Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Rose

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Molecular Pharmacology|November 1, 1979
Metabolism and metabolic effects of 8-aza-6-thioinosine and its rearrangement product, N-beta-D-ribofuranosyl-[1,2,3]thiadiazolo[5,4-d]-pyrimidin-7-amineL L Bennett, L M Rose, P W Allan, et al.
Biochemical Pharmacology|December 8, 2000
Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cellsW B Parker, S C Shaddix, L M Rose, et al.
Biochemical Pharmacology|August 25, 1995
Metabolism and metabolic actions of 4'-thiothymidine in L1210 cellsW B Parker, S C Shaddix, L M Rose, et al.
Biochemical Pharmacology|June 20, 1998
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cellsW B Parker, P W Allan, S C Shaddix, et al.
Molecular Pharmacology|June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferaseL L Bennett, R W Brockman, L M Rose, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS)N S Zeidner, L M Rose, C K Mathiason-DuBard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeysS M El Dareer, R F Struck, K F Tillery, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1S M el Dareer, K F Tillery, L M Rose, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesionsT L Richards, E C Alvord, Y He, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Molecular Pharmacology|November 1, 1979
Metabolism and metabolic effects of 8-aza-6-thioinosine and its rearrangement product, N-beta-D-ribofuranosyl-[1,2,3]thiadiazolo[5,4-d]-pyrimidin-7-amineL L Bennett, L M Rose, P W Allan, et al.
Biochemical Pharmacology|December 8, 2000
Metabolism of 4'-thio-beta-D-arabinofuranosylcytosine in CEM cellsW B Parker, S C Shaddix, L M Rose, et al.
Biochemical Pharmacology|August 25, 1995
Metabolism and metabolic actions of 4'-thiothymidine in L1210 cellsW B Parker, S C Shaddix, L M Rose, et al.
Biochemical Pharmacology|June 20, 1998
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cellsW B Parker, P W Allan, S C Shaddix, et al.
Molecular Pharmacology|June 1, 1985
Inhibition of utilization of hypoxanthine and guanine in cells treated with the carbocyclic analog of adenosine. Phosphates of carbocyclic nucleoside analogs as inhibitors of hypoxanthine (guanine) phosphoribosyltransferaseL L Bennett, R W Brockman, L M Rose, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1990
Zidovudine in combination with alpha interferon and interleukin-2 as prophylactic therapy for FeLV-induced immunodeficiency syndrome (FeLV-FAIDS)N S Zeidner, L M Rose, C K Mathiason-DuBard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1980
Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeysS M El Dareer, R F Struck, K F Tillery, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1S M el Dareer, K F Tillery, L M Rose, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 1995
Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesionsT L Richards, E C Alvord, Y He, et al.
Pageof 9